Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Blood (2024) 144 (Supplement 1): 6458.

https://doi.org/10.1182/blood-2024-202107

Published: 2024

Journal Articles

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

Xin Li, Jia Wei, Dong-feng Zeng, Shu-nan Qi, Bingzong Li, Wei Guo, Li Wang, Yajun Li, Xudong Zhang, Yong Yang, Shukai Qiao, Yan Zeng, Yunfei Song, Jing-wen Wang, Jian-min Ma, Liang Wang

Blood (2024) 144 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2024-206489

Published: 2024

Journal Articles

POD 12 As a Robust Prognostic Index in Patients with Angioimmunoblastic T-Cell Lymphoma: A Single-Center Study

Suxiao Li, Xiaoyan Feng, Jieming Zhang, Yunfei Song, Mengke Fan, Qingjiang Chen, Mingzhi Zhang, Xiaolong Wu, Meng Dong, Lijuan Han, Xudong Zhang

Blood (2024) 144 (Supplement 1): 6410.

https://doi.org/10.1182/blood-2024-207198

Published: 2024

Journal Articles

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Jiaqin Yan, Bingjie Wang, Yankui Wei, Shasha Zhang, Lei Zhang, Ling Li, Xin Li, Xiaorui Fu, Xinhua Wang, Zhenchang Sun, Xudong Zhang, Mingzhi Zhang

Blood (2024) 144 (Supplement 1): 6408.

https://doi.org/10.1182/blood-2024-206732

Published: 2024

Journal Articles

Cytokine Patterns for Secondary HLH: Experiences from a Single Center

Xiaoyan Feng, Miaomiao Meng, Zhenchang Sun, Xudong Zhang, Lei Zhang, Mingzhi Zhang

Blood (2024) 144 (Supplement 1): 4375.

https://doi.org/10.1182/blood-2024-207671

Published: 2024

Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang

Blood (2023) 142 (Supplement 1): 6847.

https://doi.org/10.1182/blood-2023-185476

Published: 2023

Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2023-174308

Published: 2023

Journal Articles

Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

Blood (2023) 142 (Supplement 1): 3471.

https://doi.org/10.1182/blood-2023-178484

Published: 2023

Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue

Blood (2023) 142 (Supplement 1): 1690.

https://doi.org/10.1182/blood-2023-188245

Published: 2023

Journal Articles

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Xudong Zhang, Wenhua Wang, Shanshan Ma, Mengke Fan, Linan Zhu, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Mingzhi Zhang

Blood (2022) 140 (Supplement 1): 12075–12076.

https://doi.org/10.1182/blood-2022-159383

Published: 2022

Journal Articles

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-137449

Published: 2020

Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Blood (2019) 134 (Supplement_1): 463.

https://doi.org/10.1182/blood-2019-127811

Published: 2019

Journal Articles

Decitabine Can Improve the Efficacy of Second-Line Chemotherapy in Relapsed or Refractory Diffuse Llarge B Cell Lymphoma

Xudong Zhang, Junxia Hu, Qingjiang Chen, Mingzhi Zhang, MD PhD, Ken H. Young

Blood (2019) 134 (Supplement_1): 5221.

https://doi.org/10.1182/blood-2019-128424

Published: 2019

Journal Articles

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Xinran Ma, MSc, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, PhD, Jingjing Wu, Xudong Zhang, Xiaoyan Feng, Zhiyuan Zhou, Yu Chang, Zhaoming Li, MD PhD, Ken H. Young, Mingzhi Zhang

Blood (2019) 134 (Supplement_1): 2873.

https://doi.org/10.1182/blood-2019-127912

Published: 2019

Journal Articles

Latent Membrane Protein 1 Contributes to Deficient Cellular Immunity in NKTCL Patients

Xiaoyan Feng, Yue Song, Zhaoming Li, MD PhD, Xudong Zhang, Lugui Qiu, MD PhD, Mingzhi Zhang, MD PhD

Blood (2019) 134 (Supplement_1): 3969.

https://doi.org/10.1182/blood-2019-128622

Published: 2019

Journal Articles

Identification of PTX3 and S100A9 As Serum Diagnostic and Therapeutic Response Biomarkers of NK/T Cell Lymphoma Patients

Zhiyuan Zhou, MD PhD, Zhaoming Li, MDPhD, Weili Xue, Xudong Zhang, MDPhD, Ken H. Young, MD PhD, Yingjun Wang, PhD, Mengyuan Jin, Mingzhi Zhang

Blood (2017) 130 (Supplement 1): 2804.

https://doi.org/10.1182/blood.V130.Suppl_1.2804.2804

Published: 2017

Journal Articles

Efficacy and Safety of Novel Targeted Drug' Apatinib in Relapse or Refractory Non-Hodgkin Lymphoma: An Open Label, Single-Armed, Exploratory Study

Ling Li, MSPH, Sa Xiao, Ken H. Young, MD PhD, Lei Zhang, MD, Xin Li, MD, Xiaorui Fu, MDPhD, Zhaoming Li, MDPhD, Zhenchang Sun, MDPhD, Xudong Zhang, MDPhD, Jiaqin Yan, MDPhD, Feifei Nan, MDPhD, Yu Chang, Mengyuan Shi, graduate student, Mingzhi Zhang

Blood (2017) 130 (Supplement 1): 1548.

https://doi.org/10.1182/blood.V130.Suppl_1.1548.1548

Published: 2017

Journal Articles

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

Weili Xue, Weiming Li, Yanjie Zhang, Yue Song, Xuan Lan, Zhaoming Li, MDPhD, Xudong Zhang, MDPhD, Ken H. Young, MD PhD, Mingzhi Zhang, Xiaoyan Feng, Guannan Wang, Zhiyuan Zhou, MD PhD, Lisha Lu, Yingjun Wang, PhD, Mengyuan Jin

Blood (2017) 130 (Supplement 1): 5149.

https://doi.org/10.1182/blood.V130.Suppl_1.5149.5149

Published: 2017

Journal Articles

GDPT Versus CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma: A Prospective Randomized Controlled, Open-Label Study (No.NCT01664975)

Ling Li, MD PhD, Wenjing Duan, graduate student, Ken H. Young, MD PhD, Zhaoming Li, MD PhD, Lei Zhang, MD PhD, Xiaorui Fu, MD PhD, Xin Li, MD PhD, Zhenchang Sun, MD PhD, Xudong Zhang, MD PhD, Jiaqin Yan, MD PhD, Feifei Nan, MD PhD, Yu Chang, MD, Li Lin, MD, Mingzhi Zhang, MD PhD

Blood (2016) 128 (22): 2989.

https://doi.org/10.1182/blood.V128.22.2989.2989

Published: 2016

Journal Articles

Primary Testicular Lymphoma:a Single Center Experience and Literature Review

Ling Li, MDPhD, Fangwen Zhang, graduate student, Ken H. Young, MD PhD, Wenjing Duan, graduate student, Zhaoming Li, MD PhD, Jiaqin Yan, MD PhD, Xiaorui Fu, MD PhD, Lei Zhang, MD PhD, Xin Li, MD PhD, Zhenchang Sun, MD PhD, Xudong Zhang, MD PhD, Yu Chang, MD, Feifei Nan, MD PhD, Mingzhi Zhang, MD PhD

Blood (2016) 128 (22): 5415.

https://doi.org/10.1182/blood.V128.22.5415.5415

Published: 2016

NARROW

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

POD 12 As a Robust Prognostic Index in Patients with Angioimmunoblastic T-Cell Lymphoma: A Single-Center Study

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Cytokine Patterns for Secondary HLH: Experiences from a Single Center

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Decitabine Can Improve the Efficacy of Second-Line Chemotherapy in Relapsed or Refractory Diffuse Llarge B Cell Lymphoma

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Latent Membrane Protein 1 Contributes to Deficient Cellular Immunity in NKTCL Patients

Identification of PTX3 and S100A9 As Serum Diagnostic and Therapeutic Response Biomarkers of NK/T Cell Lymphoma Patients

Efficacy and Safety of Novel Targeted Drug' Apatinib in Relapse or Refractory Non-Hodgkin Lymphoma: An Open Label, Single-Armed, Exploratory Study

Establishing Mouse Models of B-Cell Non-Hodgkin's Lymphoma

GDPT Versus CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma: A Prospective Randomized Controlled, Open-Label Study (No.NCT01664975)

Primary Testicular Lymphoma:a Single Center Experience and Literature Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only